Automated Anatomic Pathology Labs Transform Global Tissue Diagnostics Market
News Feb 06, 2014
Growth in diagnostic test volume conducted across hospitals worldwide is lending momentum to the global tissue diagnostics market.
In addition, the shortage of pathologists to perform these tests favors the automation of anatomic pathology laboratories, further spurring market development.
New research from Frost & Sullivan’s Analysis of the Global Tissue Diagnostics Market (http://www.lifesciences.frost.com) finds the market earned revenue of $2.39 billion in 2012 and estimates this to reach $3.45 billion in 2017.
The analysis is aimed at segmenting the market into two broad categories, namely pre-analytical and advance staining.
Automated tissue diagnostics are gaining acceptance due to the improved technical performance of the assay, which reduces reagent costs and assay time.
With anticipated technological improvements over the next three years in the advance staining and pre-analytical segments, faster turnaround times, throughput, and ease will fuel adoption.
Developments in staining technologies also showcase the ability to cost-effectively assess mutations, even multiple ones in a single test.
“The availability of tissue-based companion diagnostic tests is another important driver, especially for the U.S. and European market,” said Frost & Sullivan Life Sciences Industry Analyst Divyaa Ravishankar. “With companion diagnostic partnerships gathering pace, industry convergence has led to the addition of tissue diagnostics in the in-vitro diagnostic portfolio of most of the pharmaceutical companies.”
While increasing consolidation among laboratories and hospitals will escalate workloads and make a case for tissue diagnostic protocols, it will reduce the number of tissue diagnostics customers, forcing vendors to compete aggressively for fewer accounts.
Reimbursement cuts also impede the sale of high-end automated equipment in anatomic pathology laboratories. Use of advanced technology applications such as automatic slide stainers, microtomes and tissue processors are especially limited as they require huge capital.
“Providing attractive procurement strategies can boost the uptake of high-end tools in this constrained environment,” suggested Ravishankar. “For instance, offering competitive monthly payments, tax benefits or incentives, and deferring payments to help overcome budgetary constraints will widen the consumer base of vendors in the global tissue diagnostics market.”
Analysis of the Global Tissue Diagnostics Market is part of the Life Sciences Growth Partnership Service program. Frost & Sullivan’s related research services include: Global Analysis of MicroRNA Tools and Services, Global Mass Spectrometry Market, and Global Next Generation Sequencing Markets. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass SpecNews
Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.
Novel Microplate 3D Bioprinting Platform for Engineering Muscle and Tendon TissuesNews
There is a strong need for medication that treats age-related degenerative muscle and tendon diseases. A critical bottleneck in the discovery and development of novel drugs for skeletal muscle is the lack of efficient and robust functional in vitro assays for compound screening. Researchers describe the development of a novel screening platform with automated production of 3D muscle- and tendon–like tissues using 3D bioprinting.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE